Researcher.Life Logo

Rheumatology and Autoimmunity : Impact Factor & More

eISSN: 2767-1429pISSN: 2767-1410
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

Rheumatology and Autoimmunity Journal Specifications

Overview
Publisher Wiley-Blackwell
Language English
Article Processing ChargesUSD 3000
Publication Time11
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorChinese Medical Association
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 11
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Rheumatology and Autoimmunity ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Rheumatology and Autoimmunity

Corrigendum “Exposure to arboviral infections and risk of rheumatoid arthritis: Findings from the MyEIRA population‐based case‐control study”
  • 19 Apr 2026
  • Rheumatology & Autoimmunity
Corrigendum “immune cell alterations in a pristane‐induced lupus model in C57BL/6J mice”
  • 19 Apr 2026
  • Rheumatology & Autoimmunity
Epstein‐Barr virus as a driver of lupus: Rethinking triggers in autoimmunity
  • 13 Apr 2026
  • Rheumatology & Autoimmunity
Towards a cure for gout: A two‑stage treat‐to‐target strategy from inflammation control to structural remission
  • 13 Apr 2026
  • Rheumatology & Autoimmunity
Triptolide capsule enables proteinuria reduction and renal stabilization in advanced alport syndrome beyond standard therapy
  • 15 Mar 2026
  • Rheumatology & Autoimmunity
Performance evaluation of large language models in answering patients' questions about treatment of connective tissue diseases
  • 8 Mar 2026
  • Rheumatology & Autoimmunity
Corrigendum “Exposure to arboviral infections and risk of rheumatoid arthritis: Findings from the MyEIRA population‐based case‐control study”
  • 19 Apr 2026
  • Rheumatology & Autoimmunity
Corrigendum “immune cell alterations in a pristane‐induced lupus model in C57BL/6J mice”
  • 19 Apr 2026
  • Rheumatology & Autoimmunity
Epstein‐Barr virus as a driver of lupus: Rethinking triggers in autoimmunity
  • 13 Apr 2026
  • Rheumatology & Autoimmunity
Towards a cure for gout: A two‑stage treat‐to‐target strategy from inflammation control to structural remission
  • 13 Apr 2026
  • Rheumatology & Autoimmunity
Triptolide capsule enables proteinuria reduction and renal stabilization in advanced alport syndrome beyond standard therapy
  • 15 Mar 2026
  • Rheumatology & Autoimmunity
Performance evaluation of large language models in answering patients' questions about treatment of connective tissue diseases
  • 8 Mar 2026
  • Rheumatology & Autoimmunity

FAQs on Rheumatology and Autoimmunity